Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NativeMed vs RNK Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

NativeMed

Best for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing
★★★3.6

Starting at $149/mo

Compounded SemaglutideCompounded TirzepatideLegitScript CertifiedCash Pay
Visit NativeMed
7.3

RNK Health

Best for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship
★★★3.7

Starting at $197/mo

Compounded SemaglutideCompounded TirzepatideOral GLP-1 OptionNAD+ Add-On
Visit RNK Health

Side-by-Side Comparison

FeatureNativeMedRNK Health
Overall Score7.1/107.3/10
Starting Price$149/mo$197/mo
Editorial Rating3.6 ★ /53.7 ★ /5
Features4 features5 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

NativeMed

Pros

  • LegitScript certified per the homepage footer (independently verifiable)
  • Promotional pricing publicly displayed: $149/mo semaglutide, $183/mo tirzepatide (sale from $299/$399 regular)
  • Async questionnaire workflow with synchronous visit triggered when state law requires it

Cons

  • Pharmacy partners are NOT publicly named — material gap for YMYL disclosure (described only as 'USA-based pharmacies' / 'accredited pharmacies')
  • States served list is not publicly enumerated
  • Pricing displayed as promotional sale price — readers should confirm whether the $149/$183 holds beyond the first month or escalates to the $299/$399 'regular' price
  • Trustpilot reviews displayed on homepage — we do NOT cite Trustpilot as a primary source per editorial policy

RNK Health

Pros

  • Both injectable and oral compounded semaglutide formats — wider format optionality than most stub entries in the cluster
  • GLP-1 + longevity stack (NAD+, sermorelin, enclomiphene, DNA testing) lets one provider serve readers also interested in performance/longevity adjacencies
  • Pricing is publicly displayed — $297/mo tirzepatide, $197/mo injectable semaglutide, $198/mo oral semaglutide

Cons

  • States served not enumerated on the public landing page — needs direct confirmation before any state-page placement
  • Pharmacy partner not publicly named beyond a Springville, UT fulfillment reference
  • Compounded only on the GLP-1 side — no FDA-approved Wegovy/Zepbound brand-name option

Our Verdict

Winner: RNK HealthScore: 7.3/10

RNK Health edges out NativeMed with a higher overall score of 7.3/10 and is particularly strong for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship. NativeMed remains a solid alternative, especially if you're looking for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.